Schlitt HJ - Search Results

1

Conditioning of liver grafts with prostaglandins improves bile acid transport.

Farkas S, Bolder U, Schlittenbauer T, Obed A, Zuelke C, Anthuber M, Geissler EK, Schlitt HJ. Farkas S, et al. Among authors: schlitt hj. Transplant Proc. 2005 Jan-Feb;37(1):435-8. doi: 10.1016/j.transproceed.2004.12.299. Transplant Proc. 2005. PMID: 15808668

2

Routine monitoring of liver grafts by transplant aspiration cytology: clinical experience with 3000 TACs.

Schlitt HJ, Nashan B, Ringe B, Wonigeit K, Pichlmayr R. Schlitt HJ, et al. Transplant Proc. 1993 Apr;25(2):1970-1. Transplant Proc. 1993. PMID: 8470246 No abstract available.

3

Histochemical analysis of tissue injury in human hepatic grafts: potential usefulness in graft assessment before implantation.

Kiuchi T, Oldhafer KJ, Schlitt HJ, Nashan B, Deiwick A, Wonigeit K, Yamaoka Y, Pichlmayr R. Kiuchi T, et al. Among authors: schlitt hj. Transplant Proc. 1996 Feb;28(1):70-2. Transplant Proc. 1996. PMID: 8644344 No abstract available.

4

[Liver transplantation in elderly patients: indications, risks and results].

Schlitt HJ, Obed A, Oldhafer KJ, Manns MP, Pichlmayr R. Schlitt HJ, et al. Langenbecks Arch Chir Suppl Kongressbd. 1996;113:519-21. Langenbecks Arch Chir Suppl Kongressbd. 1996. PMID: 9101918 German.

5

Leukocyte activation and early dysfunction of liver grafts.

Schlitt HJ. Schlitt HJ. Transplantation. 2000 Apr 15;69(7):1239-40. doi: 10.1097/00007890-200004150-00006. Transplantation. 2000. PMID: 10798735 No abstract available.

6

MHC class II compatibility between donor bone marrow and secondary organ grafts is required for tolerance based on mixed chimerism.

Jäger MD, Tsui T, Timrott K, Aselmann H, Deiwick A, Neipp M, Wonigeit K, Klempnauer J, Schlitt HJ. Jäger MD, et al. Among authors: schlitt hj. Transplant Proc. 2001 Feb-Mar;33(1-2):176. doi: 10.1016/s0041-1345(00)01962-x. Transplant Proc. 2001. PMID: 11266766 No abstract available.

7

Induction of peripheral tolerance by posttransplant infusion of donor splenocytes.

Tsui TY, Jäger MD, Deiwick A, Klempnauer J, Schlitt HJ. Tsui TY, et al. Among authors: schlitt hj. Transplant Proc. 2001 Feb-Mar;33(1-2):187-8. doi: 10.1016/s0041-1345(00)01969-2. Transplant Proc. 2001. PMID: 11266773 No abstract available.

8

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice.

Koehl GE, Andrassy J, Guba M, Richter S, Kroemer A, Scherer MN, Steinbauer M, Graeb C, Schlitt HJ, Jauch KW, Geissler EK. Koehl GE, et al. Among authors: schlitt hj. Transplantation. 2004 May 15;77(9):1319-26. doi: 10.1097/00007890-200405150-00002. Transplantation. 2004. PMID: 15167584

9

Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer.

Guba M, Koehl GE, Neppl E, Doenecke A, Steinbauer M, Schlitt HJ, Jauch KW, Geissler EK. Guba M, et al. Among authors: schlitt hj. Transpl Int. 2005 Jan;18(1):89-94. doi: 10.1111/j.1432-2277.2004.00026.x. Transpl Int. 2005. PMID: 15612989 Free article.

10

Blocking MAdCAM-1 in vivo reduces leukocyte extravasation and reverses chronic inflammation in experimental colitis.

Farkas S, Hornung M, Sattler C, Edtinger K, Steinbauer M, Anthuber M, Schlitt HJ, Herfarth H, Geissler EK. Farkas S, et al. Among authors: schlitt hj. Int J Colorectal Dis. 2006 Jan;21(1):71-8. doi: 10.1007/s00384-004-0709-y. Epub 2005 Apr 23. Int J Colorectal Dis. 2006. PMID: 15856265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters